LFCRNasdaqPharmaceutical PreparationsFiscal year ends May 25
LIFECORE BIOMEDICAL, INC. DE
Financials through Q4 FY2025, quarter ended May 25, 2025Last filing: 10-Q on Aug 5, 2026
$6.39+0.01 (+0.16%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
LIFECORE BIOMEDICAL, INC. DE revenue by segment
By business segment
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reportable Segment | $128.87M | $128.26M | – | – | – | – | – | – | – | – | 100.0% | +0.5% |
| Corporate Segment [Member] | – | – | – | – | – | – | – | – | $2.36M | $2.59M | – | – |
| Food Export [Member] | – | – | – | – | – | – | – | – | $62.48M | $64.18M | – | – |
| Biomaterials [Member] | – | – | – | – | – | – | – | $65.43M | $59.39M | $50.47M | – | – |
| Packaged Fresh Vegetables [Member] | – | – | – | – | – | – | – | $454.95M | $408.02M | $423.86M | – | – |
| Other | – | – | – | $0 | $0 | $0 | $0 | $0 | $0 | $2.59M | – | – |
| Curation Foods | – | – | – | $76.47M | $73.46M | $74.23M | $481.69M | $458.80M | $410.38M | – | – | – |
| Lifecore | – | – | – | $109.32M | $98.09M | $85.83M | $75.87M | $65.43M | $59.39M | – | – | – |
By product or service
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CDMO | $90.10M | $96.62M | $76.38M | $86.35M | $75.79M | – | – | – | – | – | 69.9% | -6.7% |
| HA manufacturing | $38.77M | $31.65M | – | – | – | – | – | – | – | – | 30.1% | +22.5% |
| Contract development and manufacturing organization and Fermentation | – | – | – | $109.36M | $98.58M | – | – | – | – | – | – | – |
| Fermentation | – | – | $26.89M | $23.01M | $22.79M | – | – | – | – | – | – | – |
| Technology | – | – | – | $1.91M | $2.30M | – | – | – | – | – | – | – |
| Avocado Products | – | – | – | $0 | $0 | – | – | – | – | – | – | – |
| Other | – | $0 | $0 | $1.91M | $2.30M | – | – | – | – | – | – | – |
| Olive oil and vinegars | – | – | – | $0 | $0 | – | – | – | – | – | – | – |
| Fermentation | – | $31.65M | $26.89M | $23.01M | – | – | – | – | – | – | – | – |
By region
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Taiwan | – | – | – | – | – | – | – | – | $30.00M | $32.30M | – | – |
| Canada | – | – | – | $12.60M | $10.70M | $9.70M | $83.60M | $78.00M | $69.30M | $80.60M | – | – |
| Japan | – | – | – | – | – | – | – | – | $7.40M | $6.40M | – | – |
| Belgium | – | – | – | $0 | $13.70M | $13.80M | $15.10M | $17.20M | $21.00M | $13.40M | – | – |
| China | – | – | – | – | – | – | – | – | $8.50M | $9.40M | – | – |
| Indonesia | – | – | – | – | – | – | – | – | $12.10M | $8.30M | – | – |
| All other countries | – | – | – | $2.00M | $1.90M | $2.20M | $3.90M | $3.60M | $4.60M | $4.20M | – | – |
| International sales | – | – | – | – | – | – | – | $102.85M | $98.86M | $103.24M | – | – |
| Ireland | – | – | – | $2.20M | $2.00M | $4.00M | $5.00M | $4.10M | $4.00M | $3.20M | – | – |
| United Kingdom | – | – | – | $2.90M | $1.90M | $1.10M | – | $800.00K | $400.00K | $600.00K | – | – |
| Switzerland | – | – | – | $16.80M | $4.70M | $1.70M | $1.20M | $800.00K | $300.00K | $400.00K | – | – |
| Mexico | – | – | – | – | – | – | – | $600.00K | $500.00K | $800.00K | – | – |
| Czechia | – | – | – | $3.50M | $3.50M | $1.40M | $0 | – | – | – | – | – |
From the segment and revenue-disaggregation notes of Lifecore Biomedical, Inc. De's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.